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Abstract
BACKGROUND: Acute lymphoblastic leukemia (ALL) is one of the most common childhood hematological 
malignancies with an incident each year that tends to increase.
AIM: This study aims to determine the survival rate of childhood ALL in Dr. Wahidin Sudirohusodo General Hospital 
and the prognostic factors that influence it.
METHODS: A retrospective cohort design was conducted among childhood ALL. The samples were patients ALL 
diagnosed since January 1, 2014, until 31, 2017, in Dr. Wahidin Sudirohusodo General Hospital. A total of 109 
patients were selected by simple random sampling. Data collected through medical records observations. Data were 
analyzed using Kaplan–Meier and Cox regression analysis.
RESULTS: The cumulative survival rate of childhood ALL was 26%. The prognostic factors associated with survival 
of childhood ALL were nutritional status (p = 0.028), leukocyte counts (p = 0.000), platelet counts (p = 0.000), and 
comorbidity (p = 0.000). Based on multivariate analysis with Cox regression, the most influencing prognostic factor 
on survival of ALL patients was comorbidity (p = 0.000, hazard ratio = 3.699 confidence interval 95% 1.945–7.033). 
Childhood ALL with comorbidities had a risk of death 3699 times higher than childhood ALL without comorbidities.
CONCLUSION: Nutritional status, leukocyte counts, platelet counts, and comorbidity were prognostic factors that 
influence survival of childhood ALL. Comorbidity was the most influencing prognostic factor on survival of childhood 
ALL.
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Introduction
Cancer is one of the leading causes of death 
worldwide, including blood cancer or often called 
leukemia. Acute leukemia is the most common type 
of cancer among childhood, accounting for 97% of all 
leukemia types [1]. Acute lymphoblastic leukemia (ALL) 
is one of the most common childhood malignancies 
with an increasing incidence every year. Based on facts 
2016–2017 data by leukemia and lymphoma society 
(LLS), in 2009–2013, ALL accounted for 74.5% of new 
leukemia cases in childhood younger than 20 years [2].
The most common type of cancer suffered by 
childhood in Indonesia is leukemia [3]. The prevalence 
of ALL in South Sulawesi Province based on medical 
record data of Dr. Wahidin Sudirohusodo General 
Hospital in Makassar for the last 3 years tends to 
increase and is a disease with the highest number 
of cases in child care. In 2015, there are 60 cases, 
increasing by 2016 to 63 cases, and by 2017, there are 
67 cases [4].
The survival rate is a measure of the success 
of disease treatment. Leukemia prognostic factor 
becomes the doctor’s benchmark in determining the 
treatment to be given to the patient. A poor prognostic 
affects the body’s resistance to illness. ALL prognostic 
factors include nutritional status, leukocyte counts, 
platelet counts, and comorbidity [1], [5].
Nutritional status of patients with ALL at the 
time of diagnosis has an effect on the outcome of 
leukemia treatment. Obesity affects childhood, who 
suffers from ALL. Obese patients with ALL had a 
significantly worse survival than non-obese patients [6]. 
In addition, the study in Belanda found that underweight 
at the time of ALL diagnosis was a risk factor for relapse 
and decreased body mass index during treatment was 
associated with reduced survival [7]. The number 
of leukocytes is a factor frequently identified in ALL 
patients. Patients with leukocyte count >50,000 µl 
were associated with a low survival rate [8]. A study in 
Brazil found that the leukocyte counts of ALL patients 
had a significant effect on survival rate [9]. Leukemia 
can decrease platelet production if cancer cells spread 
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to the bone marrow. Patients with leukemia who have 
platelets <30,000 µl have a poor prognostic. Platelet 
counts were a prognostic factor that influenced the 
survival of childhood with ALL [10]. Leukemia is a 
disease of abnormal white blood cells that are immune 
cells of the human body. Disruption white blood cells 
make the body easy to get the disease, especially 
infectious diseases. Comorbidity is a poor prognostic 
factor for leukemia patients [11].
Several studies related to survival and ALL 
prognostic factors performed in some countries, 
especially in developed countries, have proved that 
prognostic factors such as nutritional status, leukocyte 
counts, platelet counts, and comorbidity are significantly 
associated with ALL survival in childhood. By examining 
the survival rate of leukemia patients, it can assist in the 
development of leukemia information and its prevention 
in the future. This study aims to determine the survival 
rates of patients with ALL in childhood in Dr. Wahidin 
Sudirohusodo General Hospital and the prognostic 
factors that influence it.
Materials and Methods
This study was conducted at Dr. Wahidin 
Sudirohusodo General Hospital, Makassar, South 
Sulawesi, Eastern Indonesia. The type of research used 
was observational analytic with retrospective cohort 
design. The population in this study was ALL patients 
diagnosed since January 1, 2014, until 31, 2017. A 
total of 109 patients were selected by simple random 
sampling. Sample criteria in this study were childhood 
aged 0–18 years when first diagnosed ALL and have 
a complete medical record and meet the criteria of 
variables studied.
Data were conducted through ALL patients 
medical record observations. The instrument used 
is the observation sheet. From the patient’s medical 
record, data were collected according to the research 
needs such as gender, address, telephone number, 
type of financing, date of first visit and date of exit or 
date of last visit, date of birth, diagnosis age, nutritional 
status, ALL characteristics, number of leukocytes, 
platelet counts, comorbidity, and patient status (life or 
death). In addition to data collection through medical 
record search, researchers also conducted a search 
through the telephone communication media to ask 
the patient’s status to the parents or family of patients. 
If the phone number of the parents or family of the 
patient cannot be contacted, then the determination 
of the patient’s status is based on the patient’s last 
condition at the last hospital control, as recorded in the 
patient’s medical record. When the patient comes out 
in good condition, then the patient is categorized as a 
sensor (survive), whereas if the patient goes out in bad 
condition, then the patient is categorized as the event 
(death).
Univariate analysis aims to describe the 
distribution of patient characteristics and research 
variables. Bivariate analysis was performed to determine 
the probability difference of survival of ALL patients 
based on the prognosis factor using Kaplan–Meier 
method with the log-rank test. Multivariate analysis was 
performed to determine the most influencing variable 
on survival of ALL patients using Cox regression 
(proportional hazard [PH] model), test performed 
simultaneously for variables that meet assumptions of 
proportional hazard.
Results
Table 1 shows the characteristics of the sample 
in this study. Of 109 LLA patients, most patients died 
(63.3%) compared to patients who survived. The 
majority of ALL patients were in the 1–10 year age group 
(76.1%). Most ALL patients were men (60.6%). Based 
Table 1: Distribution of patient characteristics
Characteristics n F
Survival status
Event 69 63.3
Sensor 40 36.7
Age diagnosis (years)
<1 3 2.8
1–10 83 76.1
>10 23 21.1
Gender
Male 66 60.6
Female 43 39.4
Risk grouping ALL
High risk 59 54.1
Standard risk 50 45.9
ALL: Acute lymphoblastic leukemia.
Figure 1: Survival rate childhood acute lymphoblastic leukemia
on ALL risk grouping, according to the National Cancer 
Institute, more than half of ALL patients (54.1%) are 
categories high risk. The cumulative proportion of ALL 
survival in childhood who reached 4 years (48 months) 
was 26% (Figure 1).
T2 - Thematic Issue “Public Health and Nutrition Sciences in the Current Millennial Era” Public Health Disease Control
206 https://www.id-press.eu/mjms/index
Most of the ALL patients who died were patients 
with abnormal nutritional status (71.4%). Based on 
leukocyte counts and platelet counts, most of the ALL 
patients who died were patients with leukocyte counts 
>50,000 µl (82.9%) and platelet counts <30,000 µl 
(82.1%). Based on comorbidity, the most died patients in 
patients with comorbidity (85.1%) (Table 2). Differences 
in the survival of patients with ALL in childhood based on 
prognostic factors are presented in Figure 2. The survival 
curve of ALL patients based on nutritional status, leukocyte 
counts, platelet counts, and comorbidity do not intersect. 
This shows the assumption PH fulfilled, with p-value (log 
rank) <0.05. That is, there is a significant relationship 
between nutritional status, leukocyte counts, platelet 
counts, and comorbidity with the survival of ALL patients.
Table 2: Distribution of LLA patients based on research 
variables and survival status
Research variable Survival status Total p (log rank)
Died Survive
n F n F n F
Nutritional status 0.028*
Abnormal 50 71.4 20 28.6 70 100
Normal 19 48.7 20 51.3 39 100
Leukocyte counts (µl) 0.000*
>50,000 29 82.9 6 17.1 35 100
<50,000 40 54.1 34 45.9 74 100
Platelet counts (µl) 0.000*
<30,000 46 82.1 10 17.9 56 100
>30,000 23 43.3 30 56.6 53 100
Comorbidity 0.000*
Yes 57 85.1 10 14.9 67 100
No 12 28.6 30 71.4 42 100
ALL patients survival rate based on nutritional 
status that is abnormal nutrition was 16%, whereas 
normal nutrition was 46%. The survival rate based on 
the leukocyte counts is the leukocyte counts >50,000 
µl was 8%, while the leukocyte counts <50,000 µl was 
34%. The survival rate based on the platelet counts is 
the platelet counts <30,000 µl was 13%, whereas the 
platelet counts >30,000 µl was 41%. The survival rate 
of ALL patients is based on comorbidity which was 8% 
and without comorbidity was 70% (Figure 2).
Table 3 shows that variables having p < 0.05 
were platelet counts and comorbidity. Among the two 
variables, the comorbidity variable has the highest 
hazard ratio value of 3.699 confidence interval 95% 
1.945–7.033. Thus, comorbidity is the variable that has 
the most dominant influence on survival of ALL patients. 
Childhood ALL with comorbidities had a risk of death 3699 
times higher than childhood ALL without comorbidities.
Table 3: Results Cox regression analysis multivariate
Variable B SE Wald Sig. HR 95% CI for HR
Lower Upper
Nutritional status −0.96 0.303 0.101 0.750 0.908 0.501 1.645
Leukocyte counts 0.357 0.259 1.907 0.167 1.430 0.861 2.375
Platelet counts 1.107 0.300 13.637 0.000 3.027 3.027 5.448
Comorbidity 1.308 0.328 15.913 0.000 3.699 1.945 7.033
CI: Confidence interval, HR: Hazard ratio, SE: Standard error.
Discussion
This study shows that the 4-year survival rate 
of childhood ALL in Dr. Wahidin Sudirohusodo General 
Hospital was 26%. Prognosis factors associated with 
the survival rate of childhood ALL were nutritional 
status, leukocyte counts, platelet counts, and 
comorbidity.
Survival rate in this study was lower than 
a study in Yogyakarta, where the survival rate of 
childhood with ALL was 56.1% [12]. In addition, there 
was a significant difference between ALL survival rates 
in this study and two studies conducted in Brazil and 
Germany [13], [14]. Survival rates of both studies are 
over 75%. This shows the survival rate of ALL patients 
in developing countries is still very low when compared 
with developed countries as Brazil and Germany. 
The difference in survival rates for patients with ALL 
is likely due to differences in patient conditions such 
as individual factors, cancer factors, and leukemia 
management factors in each study site. In addition, 
follow-up different lengths of also caused a difference 
in survival rate.
The low proportion of survival of ALL patients 
in childhood diagnosed in Dr. Wahidin Sudirohusodo 
Makassar is caused by several factors, as there are 
many patients who refuse chemotherapy and do not 
continue treatment because of side effects caused by 
a combination of cytostatic drugs on chemotherapy 
treatment. In addition, many patients are returning at 
their own request under adverse conditions so that 
many ALL patients die of not continuing treatment. 
One of the prognostic factors associated with 
survival of patients with ALL in childhood in Dr. Wahidin 
Sudirohusodo General Hospital is nutritional status. 
Most ALL patients with abnormal nutritional status 
(71.4%) were died. The proportion of survival of 
patients with abnormal nutrition is lower than that of ALL 
patients with normal nutrition. The results of this study 
are in line with research Eissa, Galilee, and Orgel, who 
concluded that obesity affects the prognosis of ALL 
patients in childhood [6], [15], [16]. Obese patients with 
ALL had a significantly worse survival than non-obese 
patients. One of the risk factors for leukemia is due to 
gene mutation. Obesity may speed up the rate of cell 
mutation or disrupt the cellular mechanism of DNA 
repair that results in mutation events [17]. Therefore, 
ALL patients with abnormal nutrition tend to have a 
poor prognosis. It is important to develop interventions 
to reduce obesity prevalence by a focus on behavioral 
therapy [18].
The study also showed a correlation between 
leukocyte counts and survival of ALL patients in 
childhood. The most deaths were in patients with 
leukocyte counts >50,000 µl (82.9%). The proportion 
of survival of patients with leukocyte counts >50,000 
µl was lower than that in ALL patients with leukocyte 
counts <50,000 µl. The results of this study are in line 
with research Sousa, Rujkijyanont, Gupta, and Parvareh 
who found that the number of leukocytes at the time of 
diagnosis was related to the probability of survival of 
childhood with ALL [9], [19], [20], [21]. The leukocyte 
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counts above 100 × 109/L is a prognostic factor of 
induction phase failure in chemotherapy treatment [22].
Leukemia can decrease platelet production if 
cancer cells spread to the bone marrow. This study found 
an association between platelet counts and survival of 
ALL patients in childhood. Most patients with platelet 
counts <30,000 µl (82.1%) were died. The proportion of 
survival in patients with platelet counts <30,000 µl lower 
than the ALL patients with platelet counts >30,000 µl. 
Patients with platelet counts <30,000 µl may experience 
bleeding even if under no activity conditions. This may 
worsen the condition of the ALL patient. The results 
of this study were not different from those of Almasi-
Hashiani in Iran and Kulkarni in India, which found that 
platelet counts were a prognostic factor that influenced 
the survival of childhood with ALL [10], [23]. The results 
of this study are also in line with the theory that patients 
with ALL who have platelet counts <30,000/mm³ have a 
poor prognosis [5].
The comorbidities in this study were 
comorbidities other than ALL diagnoses that occurred 
when patients underwent treatment that could affect 
the patient’s condition. The results of this study 
indicate an association between comorbidity and 
survival of ALL patients. The most deaths were in 
patients with comorbidity (85.1%). The presence of 
comorbidity is a poor prognostic factor for leukemia 
patients. The most common comorbidities in this 
study were thrombocytopenia (48.6%), then anemia 
(47.7%), neutropenia (31.2%), hyperleukocytosis 
(21.1%), underweight (20.2%), sepsis (17.4%), 
and caries dentist (13.8%). Most ALL patients have 
comorbidities of more than one disease. The results 
of this study are in line with Simanjorang’s research, 
which concluded that patients with comorbidity had 
5% survival probability of 0% [11]. That is, patients 
who have comorbidities have died before 5 years. 
Disruption of white blood cells causes the body easy to 
get the disease. In addition, leukemia patients become 
susceptible to other diseases due to interventions 
such as chemotherapy, stem cell transplantation, 
and radiation that can cause deficiency of the body. 
The therapy also results in skin and mucosal growth 
Figure 2: (a-d) Survival rate childhood acute lymphoblastic leukemia according to nutritional status, leukocyte count, platelet count, and 
comorbidity with Kaplan–Meier method
a
b d
c
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disorders in the digestive tract making it susceptible to 
bacterial infections [24].
Conclusion
Survival rate of childhood ALL in Dr. Wahidin 
Sudirohusodo General Hospital Makassar was 26%. 
The prognostic factors significantly associated with 
ALL survival were nutritional status, leukocyte counts, 
platelet counts, and comorbidity. The most influential 
prognostic factor for ALL survival is comorbidity. 
Stratification of leukemia treatment based on 
prognostic factors associated with ALL patient survival 
needs to be done to improve treatment success. 
Recommendation
Research needs to be done on the evaluation 
of cytostatic side effects on the treatment of leukemia 
(chemotherapy) to prevent the occurrence of 
comorbidities in ALL patients that may affect the 
outcome of patient treatment.
References
1. Permono B, Ugrasena I. Buku Ajar Hematologi-Onkologi Anak. 
Jakarta: Ikatan Dokter Anak Indonesia; 2012.
2. LLS. Fact 2016-2017. New York: Leukemia & Lymphoma 
Society; 2018.
3. Kemenkes RI. Control Cancer in Children. Jakarta: Republic of 
Indonesia’s Ministry of Health; 2016.
4. Medical Record of Dr. Wahidin Sudirohusodo General Hospital 
Makassar. Data on Acute Leukemia Inpatient Patients 2012-
2017. Makassar: Dr. Wahidin Sudirohusodo General Hospital 
Makassar; 2018. https://doi.org/10.15562/jdmfs.v13i3.413
5. Wirawan. Diagnostic acute lymphocytic leukemia: Morphology, 
immunophenotype, cytogenetic, and molecular. Majalah Kedokt 
Indones. 2003;53(1).
6. Eissa H, Zhou Y, Panetta J, Browne E, Jeha S, Cheng C, et al. 
The effect of body mass index at diagnosis on clinical outcome 
in children with newly diagnosed acute lymphoblastic leukemia. 
Blood Cancer J. 2017;7(2):e531. https://doi.org/10.1038/
bcj.2017.11
 PMid:28212374
7. Hoed M, Pluijm SM, de Groot-Kruseman HA, Te Winkel ML, van 
den Akker EL, Hoogerbrugge P, et al. The negative impact of 
being underweight and weight loss on survival of children with 
acute lymphoblastic leukemia. Haematologica. 2015;100(1):62-
9. https://doi.org/10.3324/haematol.2014.110668
 PMid:25304613
8. Robison LL. Late effects of acute lymphoblastic leukemia 
therapy in patients diagnosed at 0-20 years of age. Hematology 
Am Soc Hematol Educ Program. 2011;2011(1):238-42. https://
doi.org/10.1182/asheducation-2011.1.238
 PMid:22160040
9. Sousa DW, Ferreira FV, Félix FH, Lopes MV. Acute 
lymphoblastic leukemia in children and adolescents: Prognostic 
factors and analysis of survival. Rev Bras Hematol Hemoter. 
2015;37(4):223-9.
10. Almasi-Hashiani A, Zareifar S, Karimi M, Khedmati E, 
Mohammadbeigi A. Survival rate of childhood leukemia in 
Shiraz, Southern Iran. Iran J Pediatr. 2013;23(1):53-8.
 PMid:23550191
11. Simanjorang C, Kodim N, Tehuteru E. 5-year survival difference 
acute lymphoblastic leukemia patients and acute mieloblastic 
leukemia in children at “Dharmais” cancer hospital, Jakarta, 
1997-2008. Indones J Cancer. 2013;7(1):15-21.
12. Wijayanti LP, Supriyadi E. Faktor prognostics and survival 
of children acute lymphoblastic leukemia patients in Dr. 
Sardjito Hospital, Yogyakarta, 2010-2015. Indones J Cancer. 
2017;11(4):145-50.
13. Lins MM, Santos MO, Albuquerque MF, Castro CC, Mello MJ, 
Camargo B. Incidence and survival of childhood leukemia 
in Recife, Brazil: A population-based analysis. Pediatr Blood 
Cancer. 2017;64(8):1-6. https://doi.org/10.1002/pbc.26391
 PMid:28000427
14. Erdmann F, Kaatsch P, Zeeb H, Roman E, Lightfoot T, Schüz J. 
Survival from childhood acute lymphoblastic leukaemia in 
West Germany: Does socio-demographic background matter? 
Eur J Cancer. 2014;50(7):1345-53. https://doi.org/10.1016/j.
ejca.2014.01.028
15. Gelelete CB, Pereira SH, Azevedo AM, Thiago LS, Mundim M, 
Land MG, et al. Overweight as a prognostic factor in children 
with acute lymphoblastic leukemia. Obesity (Silver Spring). 
2011;19(9):1908-11. https://doi.org/10.1038/oby.2011.195
 PMid:21720424
16. Orgel E, Tucci J, Alhushki W, Malvar J, Sposto R, Fu CH, 
et al. Obesity is associated with residual leukemia following 
induction therapy for childhood B-precursor acute lymphoblastic 
leukemia. Blood. 2014;124(26):3932-8. https://doi.org/10.1182/
blood-2014-08-595389
 PMid:25349177
17. Lichtman MA. Obesity and the risk for a hematological 
malignancy: Leukemia, lymphoma, or myeloma. 
Oncologist. 2010;15(10):1083-101. https://doi.org/10.1634/
theoncologist.2010-0206
 PMid:20930095
18. Asnidar A, Arsunan AA, Ayu EK, Suriah, Muriyati. Knowledge, 
food intake pattern, and body mass index of overweight 
and obese adolescent before and after giving social 
media health education in Bulukumba regency. Indian 
J Public Health Res Dev. 2018;9(9):160-5. https://doi.
org/10.5958/0976-5506.2018.00987.7
19. Rujkijyanont P, Kaewinsang S, Monsereenusorn C, Traivaree C. 
Pediatric acute leukemia: The effect of prognostic factors 
on clinical outcomes at phramongkutklao hospital, Bangkok, 
Thailand. J Med Assoc Thai. 2014;97(2):S188-95.
 PMid:25518193
20. Gupta S, Sutradhar R, Guttmann A, Sung L, Pole JD. 
Socioeconomic status and event free survival in pediatric acute 
lymphoblastic leukemia: A population-based cohort study. 
Leuk Res. 2014;38(12):1407-12. https://doi.org/10.1016/j.
leukres.2014.08.017
 PMid:25224660
21. Parvareh M, Khanjani N. The survival of childhood leukemia 
and its related factors in Kerman, Iran. Iran J Health Sci. 
2015;3(4):24-32.
22. Oudot C, Auclerc MF, Levy V, Porcher R, Piguet C, Perel 
Y, et al. Prognostic factors for leukemic induction failure in 
children with acute lymphoblastic leukemia and outcome 
after salvage therapy: The FRALLE 93 study. J Clin Oncol. 
 Arsunan et al. Prognostic Factors and Survival Rate of Childhood Acute Lymphoblastic Leukemia
Open Access Maced J Med Sci. 2020 Sep 25; 8(T2):204-209. 209
2008;26(9):1496-503. https://doi.org/10.1200/jco.2007.12.2820
 PMid:18349402
23. Kulkarni KP, Marwaha RK, Trehan A, Bansal D. Survival 
outcome in childhood ALL: Experience from a tertiary care 
Centre in North India. Pediatr Blood Cancer. 2009;53(2):168-73. 
https://doi.org/10.1002/pbc.21897
24. Hadianto MT. Differences in Interleukin-8 Levels in Bacterial 
Infection and Non-Infection in Leukemia Children with 
Neutropenia Fever, Thesis. Indonesia: Diponegoro University; 
2011.
